Annual Drug Patent Expirations for WINLEVI
Winlevi is a drug marketed by Sun Pharm and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.
This drug has seventy patent family members in twenty-six countries.
The generic ingredient in WINLEVI is clascoterone. One supplier is listed for this compound. Additional details are available on the clascoterone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
